Pinned Tweet
Video explainer from @guardian on the COVID-19 vaccines. What in them and how do they work? youtu.be/js7zmq8ph5o
Adam Finn retweeted
🔬 Exciting New Podcast! 🎧
Join us for a captivating episode where we delve into Pediatric Infectious Diseases with Sir Andrew Pollard & Prof. Adam Finn.
Discover how the pandemic affected children & gain unique insights.
@adamhfinn | @OxPaediatrics
Listen now!
Simplify manuscript submissions in academic journals! - Sign the Petition! chng.it/v267T74m via @UKChange
Remarkable preprint: zoster vaccine reduced dementia rates by ~20% over a 7y period. The way it was rolled out in Wales was a "natural experiment", indicating causality. Need to know if Shingrix does the same. doi.org/10.1101/2023.05.23.2…
New from the UNCOVER group which made use of samples stored pre-pandemic in the Bristol Biobank. The capacity of COVID19 vaccines to induce mucosal immune responses so far has been disappointing - more attention to salivary IgA responses needed in future doi.org/10.1038/s43856-023-0…
First ever RSV vaccine licensed by FDA. This one is for elderly adults. After years of no options for RSV suddenly there is about to be a plethora of tools to prevent it both in infants and old people gsk.com/en-gb/media/press-re…
Latest pre-print from the Bristol UNCOVER group - working towards a thermostable protein nanoparticle vaccine "ADDomer" against COVID19 biorxiv.org/content/10.1101/…
Adam Finn retweeted
Trends in serotype distribution and disease severity in adults hospitalised with Streptococcus pneumoniae infection in Bristol and Bath: a retrospective cohort study, 2006-2022 medrxiv.org/cgi/content/shor… #medRxiv
Adam Finn retweeted
Do #bivalent mRNA boosters offer equivalent protection to monovalent mRNA #COVID19 #vaccines? We try to answer this in our new #COVIDVACCINE paper from #avoncap
@BristolUncover @BristolARU @ResearchNBT @adamhfinn @AChatzilena @leondanon
medrxiv.org/content/10.1101/…
Adam Finn retweeted
Do you work with bovine tuberculosis (bTB)-infected cattle?
If yes @BrisPopHealth wants you to take part in the ZooTB study.
Come to The White Hart, Congresbury on Monday 13 March to find out more and sign up.
👉 fal.cn/3ws2E
#bovineTB
@n3113n
@amyc_thomas
JCVI recs on 2023 spring booster now published: gov.uk/government/publicatio…
jitsuvax.info is now live. Understanding vaccine hesitancy. Helping “immunise” people against misinformation.
Bristol Vaccine Centre vacancy for clinical research manager. Closing date 12th October. Please forward to anyone you know who might be interested bristol.ac.uk/jobs/find/deta… Informal enquiries to [email protected]
Adam Finn retweeted
Our latest preprint, estimating effectiveness of BNT162b2 COVID-19 Vaccination in Prevention of Hospitalisations and Severe Disease in Adults with Delta & Omicron SARS-CoV-2 Infection
@leondanon
@adamhfinn
@AChatzilena @rjchallen
papers.ssrn.com/sol3/papers.…
Final peer-reviewed publication on interim analysis of Valneva phase 3 trial that supported MHRA and EMA approval now available at: sciencedirect.com/science/ar…
We looked carefully at lower respiratory tract disease admissions in Bristol during delta and omicron waves. Taking everything into account, omicron admissions are less severe even though patients are on average older. medrxiv.org/content/10.1101/…
Valneva Phase I/II trial peer review publication now out. Dose finding vs NeutABs, low reactogenicity, broad Cell mediated responses. Vaccine now licensed/authorised in EU/UK. Thanks to all sites and participants. sciencedirect.com/science/ar…
EMA CHMP have today recommended market authorisation of Valneva COVID19 vaccine in the EU. Another step forward for this vaccine thanks to work done by research teams in the UK and thousands of UK study participants. valneva.com/press-release/va…








